Skip to Main Content

Paper Details

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.
Science
4302
2017
Mismatch repair deficiency, PD-1, cancers, colorectal cancers, genomes, mismatch repair deficiency, mismatch repair-deficient cancers, mutant neopeptides, neoantigen-specific T cell clones, patient, patients, solid tumors, tumor
Author NameAffiliation
Tim F GretenCenter for Cancer Research, National Cancer Institute
Ludmila DanilovaBloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins
Ludmila DanilovaSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Ludmila DanilovaBloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins
Ludmila DanilovaSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Leslie CopeBloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins
Leslie CopeSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Christian F MeyerSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
David Spetzler
Nianqing Xiao
Nickolas PapadopoulosSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Nickolas PapadopoulosLudwig Center and Howard Hughes Medical Institute at Johns Hopkins
Kenneth W KinzlerSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Kenneth W KinzlerLudwig Center and Howard Hughes Medical Institute at Johns Hopkins
Bert VogelsteinBloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins
Bert VogelsteinSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Bert VogelsteinLudwig Center and Howard Hughes Medical Institute at Johns Hopkins
  • 1 - 17

Datasets

Release 1.2